
Balraj Singh
Researcher from the Department of Breast Surgical Oncology at The University of Texas MD Anderson Cancer Center
Best podcasts with Balraj Singh
Ranked by the Snipd community

Sep 19, 2022 • 9min
Behind the Study: Inhibition of Resistant Triple-negative Breast Cancer Cells
Dr. Balraj Singh, a researcher from The University of Texas MD Anderson Cancer Center, discusses inhibiting resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine. They explore the efficacy of these drugs and their potential to overcome chemotherapy resistance. The podcast also delves into the use of 6MP in enhancing immune checkpoint blockage for combating autoimmunity and cancer cells.